During the past decade, St Vincent's Hospital Sydney conducted 237 clinical trials. In the 10-year time frame, 237 clinical trials started and 86 clinical trials were completed, i.e. on average, 36.3% percent of trials that started reached the finish line to date. In the past 5 years, 109 clinical trials started and 58 clinical trials were completed. i.e. 53.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St Vincent's Hospital Sydney" #1 sponsor was "Kirby Institute" with 44 trials, followed by "Gilead Sciences" with 28 trials sponsored, "Eli Lilly and Company" with 17 trials sponsored, "Australian and New Zealand Intensive Care Research Centre" with 11 trials sponsored and "Janssen Research & Development, LLC" with 11 trials sponsored. Other sponsors include 258 different institutions and companies that sponsored additional 145 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St Vincent's Hospital Sydney" #1 collaborator was "National Health and Medical Research Council, Australia" with 17 trials as a collaborator, "Merck Sharp & Dohme LLC" with 15 trials as a collaborator, "The University of New South Wales" with 10 trials as a collaborator, "Bristol-Myers Squibb" with 9 trials as a collaborator and "St Vincent's Hospital, Sydney" with 8 trials as a collaborator. Other collaborators include 280 different institutions and companies that were collaborators in the rest 203 trials.

According to Clinical.Site data, the most researched conditions in "St Vincent's Hospital Sydney" are "HIV Infections" (25 trials), "Pulmonary Arterial Hypertension" (19 trials), "Pulmonary Hypertension" (12 trials), "Prostate Cancer" (11 trials) and "HIV" (10 trials). Many other conditions were trialed in "St Vincent's Hospital Sydney" in a lesser frequency.

Most popular intervention types in "St Vincent's Hospital Sydney" are "Drug" (272 trials), "Biological" (44 trials), "Other" (35 trials), "Device" (30 trials) and "Procedure" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (55 trials), "Atezolizumab" (10 trials), "Abemaciclib" (9 trials), "Cisplatin" (7 trials) and "Nivolumab" (7 trials). Other intervention names were less common.

The vast majority of trials in "St Vincent's Hospital Sydney" are 341 trials for "All" genders, 27 trials for "Male" genders and 6 trials for "Female" genders.

Currently, there are 138 active trials in "St Vincent's Hospital Sydney". 2 are not yet recruiting, 70 are recruiting, 62 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 172 completed trials in St Vincent's Hospital Sydney, undefined suspended trials, and 48 terminated clinical trials to date.

Out of the total trials that were conducted in St Vincent's Hospital Sydney, 46 "Phase 1" clinical trials were conducted, 94 "Phase 2" clinical trials and 141 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 32 trials, and there were also 38 trials that are defined as “Not Applicable".

St Vincent's Hospital Sydney has several departments that took part in Clinical trials: "St Vincent's Hospital HIV, Immunology and Infectious Disease Unit" - 3 trials, "St Vincent's Hospital Sydney; Neurology" - 2 trials